account_id none on file
legal_name Abvc Biopharma, Inc.
ticker ABVC
cik 1173313
domain abvcpharma.com
linkedin_company_url https://www.linkedin.com/company/abvc-biopharma/
entry_point_account_id none on file
name ABVC BioPharma Inc.
exchange Nasdaq
sector Health Care
hq Fremont, CA, United States
sector index/company/sector/health-care/
calls 0 filings 1 executives 5 family 0
why_nownone on file
callsnone on file
filings
on the demand for our products; the duration of the COVID-19 outbreak and severity of such outbreak in regions where we operate; the pace of recovery following the COVID-19 outbreak; our ability to implement cost containment and business recovery strategies; the adverse effects of the COVID-19 outbreak on our business or the market price of our ordinary shares; competition in the industry in which we operate and the
filing / Aug 12, 2026 / receipt
executives
| Chihliang An | Chief Financial Officer | - | receipt |
| Eugene Jiang | Chief Business Officer | - | receipt |
| Howard Doong | CEO | - | receipt |
| Leeds Chow | Chief Financial Officer | receipt | |
| Yu-Min (Francis) Chung | director | - | receipt |
familynone on file
upcoming
| 2026-10-30 | earnings call | scheduled | ir |
changes
| 2022-09-09 | Chief Financial Officer, appointed | sec_8k |
| 2022-07-14 | director, appointed | sec_8k |
| 2019-08-27 | Chief Business Officer, appointed | sec_8k |
| 2019-08-27 | Chief Financial Officer, appointed | sec_8k |
| 2018-05-10 | CEO, appointed | sec_8k |
| 2018-05-10 | Chief Financial Officer, departed | sec_8k |
| 2017-09-20 | CEO, appointed | sec_8k |
| 2015-12-18 | CEO, appointed | sec_8k |
| 2009-03-26 | Chief Financial Officer, departed | sec_8k |
| 2009-03-26 | Chief Financial Officer, departed | sec_8k |
| 2009-03-26 | Chief Financial Officer, departed | sec_8k |
| 2009-03-26 | Chief Financial Officer, departed | sec_8k |
mcp_package_hint
slug abvc-biopharma-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$